DE69906728D1 - Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen - Google Patents

Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen

Info

Publication number
DE69906728D1
DE69906728D1 DE69906728T DE69906728T DE69906728D1 DE 69906728 D1 DE69906728 D1 DE 69906728D1 DE 69906728 T DE69906728 T DE 69906728T DE 69906728 T DE69906728 T DE 69906728T DE 69906728 D1 DE69906728 D1 DE 69906728D1
Authority
DE
Germany
Prior art keywords
neural development
development disorders
methanol derivatives
piperidine methanol
treating neural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906728T
Other languages
English (en)
Other versions
DE69906728T2 (de
Inventor
Maria Carlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurosearch Sweden AB
Original Assignee
A Carlsson Research AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Carlsson Research AB filed Critical A Carlsson Research AB
Publication of DE69906728D1 publication Critical patent/DE69906728D1/de
Application granted granted Critical
Publication of DE69906728T2 publication Critical patent/DE69906728T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69906728T 1998-04-30 1999-04-26 Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen Expired - Fee Related DE69906728T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9801516A SE9801516D0 (sv) 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism
SE9801516 1998-04-30
PCT/SE1999/000683 WO1999056750A1 (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders

Publications (2)

Publication Number Publication Date
DE69906728D1 true DE69906728D1 (de) 2003-05-15
DE69906728T2 DE69906728T2 (de) 2004-02-26

Family

ID=20411144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906728T Expired - Fee Related DE69906728T2 (de) 1998-04-30 1999-04-26 Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen

Country Status (13)

Country Link
US (1) US6358977B1 (de)
EP (1) EP1082116B1 (de)
JP (1) JP2002513759A (de)
AT (1) ATE236634T1 (de)
AU (1) AU4301699A (de)
CA (1) CA2330568A1 (de)
DE (1) DE69906728T2 (de)
DK (1) DK1082116T3 (de)
ES (1) ES2197675T3 (de)
NZ (1) NZ508422A (de)
PT (1) PT1082116E (de)
SE (1) SE9801516D0 (de)
WO (1) WO1999056750A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
DE10212564B4 (de) 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
CN1305871C (zh) * 2002-07-19 2007-03-21 比奥维特罗姆股份公司 用于治疗与5－ht2a受体有关疾病的新哌嗪基－吡嗪酮衍生物
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
JP4646574B2 (ja) * 2004-08-30 2011-03-09 株式会社日立製作所 データ処理システム
EP1842556A4 (de) * 2005-01-18 2008-12-17 Mitsubishi Tanabe Pharma Corp Therapeutisches mittel bei aufmerksamkeitsdefiziten und hyperaktivität

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992546A (en) * 1973-10-18 1976-11-16 Ciba-Geigy Corporation 4-Piperidinobutyrophenones as neuroleptics
ZA864772B (en) * 1985-07-02 1987-02-25 Merrell Dow Pharma Novel chemical compounds
JP2869512B2 (ja) * 1990-06-01 1999-03-10 メレルダウファーマスーティカルズ インコーポレイテッド （＋）―α―（２，３―ジメトキシフェニル）―１―［２―（４―フルオロフェニル）エチル］―４―ピペリジンメタノール
US5618824A (en) 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists

Also Published As

Publication number Publication date
JP2002513759A (ja) 2002-05-14
ATE236634T1 (de) 2003-04-15
US6358977B1 (en) 2002-03-19
WO1999056750A1 (en) 1999-11-11
EP1082116B1 (de) 2003-04-09
EP1082116A1 (de) 2001-03-14
AU4301699A (en) 1999-11-23
SE9801516D0 (sv) 1998-04-30
NZ508422A (en) 2002-05-31
DK1082116T3 (da) 2003-07-21
DE69906728T2 (de) 2004-02-26
ES2197675T3 (es) 2004-01-01
CA2330568A1 (en) 1999-11-11
PT1082116E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
MY117896A (en) Quinazoline derivatives
ATE92316T1 (de) Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE69906728D1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ATE245419T1 (de) Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE186215T1 (de) Verwendung von n-(pyridinyl)-1h-indol-1-aminen zur herstellung eines medikamentes zur behandlung von zwangsneurotischen erkrankungen
BR0317289A (pt) Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
NO307406B1 (no) Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
HU912901D0 (en) Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
DE69619868D1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
MX9703712A (es) Derivados de 6-metoxi-1h-benzotriazol-5-carboxamida, sus procesos de produccion y las composiciones farmaceuticas que los contienen.
SE9700803D0 (sv) Farmaceutisk komposition för behandling av s k restless legs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee